Speeding the SynBio Revolution: Spotlight Talk with Agilent

Speeding the SynBio Revolution: Spotlight Talk with Agilent

Tuesday, September 29, 2020 11:20 PM to 11:25 PM · 5 min. (Africa/Abidjan)

Information

Synthetic biology approaches to engineering biological systems and organisms have driven innovations in both DNA and RNA synthesis. Agilent brings novel tools into the reach of every molecular biology lab, improving the speed and efficiency of genome engineering. 

AgilentAgilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com">www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom">Newsroom. Follow Agilent on LinkedIn">LinkedIn, Twitter">Twitter, and Facebook">Facebook. 

Registered attendees

Brittany Niccum
Brittany Niccum
Product ManagerBeckman Coulter Life Sciences
Cherie Ochsenfeld
Cherie Ochsenfeld
Data ScientistPairwise
EB
Ericka Bermudez
ScientistCodexis

Log in